Novo Nordisk Expands Wegovy Price Cut Program, Stock Still Falls 2%
NVO's shares are down 2% despite making Wegovy available at a discounted price of $499 per month at local pharmacies.
Becker's Hospital Review1d
Will FDA deadlines reduce compounded versions of Ozempic?
With a FDA deadline set for March 26 to stop compounding versions of Zepbound, followed by restrictions on compounded Ozempic ...
Fierce Pharma1d
Novo Nordisk offers cheaper Wegovy for all cash-paying patients at retail pharmacy
Novo Nordisk has quickly expanded its discounted Wegovy program, now offering all eligible cash-paying customers its popular ...
Managed Healthcare Executive1d
Novo Nordisk Extends Lowered Wegovy Price to Retail Pharmacies
Wegovy is also available through NovoCare Pharmacy, which directly ship all dose strengths at a cost of $499 per month for ...
Zepbound copycats remain online despite FDA ban
Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...
Why cheaper alternatives to weight-loss drugs like Wegovy, Zepbound will be tougher to get
The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
BC Technology4d
Lexaria's DehydraTECH-tirzepatide Oral Capsules Achieve Comparable Levels in Bloodstream as Eli Lilly’s Injectable Weight Loss Drug Zepbound(R)
Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide ("FTS") rodent biodistribution study.
Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market
Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...
Eli Lilly’s weight-loss drug Mounjaro comes to India, eyes big market with increasing obesity and diabetes risk
Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India after receiving regulatory approval. The launch ...
Eli Lilly’s diabetes and weight-loss drug Mounjaro debuts in India
Investing.com -- U.S. pharmaceutical company Eli Lilly (NYSE: LLY) has introduced its diabetes and weight-loss drug Mounjaro ...
Weight-loss drug Mounjaro now in India: What is the price? What are the side effects? Here's all you need to know
Eli Lilly launched its diabetes and weight-loss drug Mounjaro in India, ahead of Novo Nordisk, aiming at a market grappling ...
Mounjaro Launched in India: Price To Side-Effects, All You Need To Know About Ozempic-Like Weight Loss Drug
Eli Lillys famous weight loss drug will now be sold in India after the drug maker received approval from CDSCO. What are its ...